These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9708807)

  • 21. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
    Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
    J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical study of the receptors for retinoic acid in prostatic adenocarcinoma.
    Kikugawa T; Tanji N; Miyazaki T; Yokoyama M
    Anticancer Res; 2000; 20(5C):3897-902. PubMed ID: 11268473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of retinoid-X receptors (-alpha,-beta,-gamma) and retinoic acid receptors (-alpha,-beta,-gamma) in normal human skin: an immunohistological evaluation.
    Reichrath J; Mittmann M; Kamradt J; Müller SM
    Histochem J; 1997 Feb; 29(2):127-33. PubMed ID: 9147069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
    Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ
    Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
    Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
    Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of nuclear retinoic acid receptor and retinoid X receptor mRNA in the cornea and conjunctiva.
    Bossenbroek NM; Sulahian TH; Ubels JL
    Curr Eye Res; 1998 May; 17(5):462-9. PubMed ID: 9617539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines.
    Raffo P; Emionite L; Colucci L; Belmondo F; Moro MG; Bollag W; Toma S
    Anticancer Res; 2000; 20(3A):1535-43. PubMed ID: 10928067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced expression and growth inhibitory activity of the aging suppressor klotho in epithelial ovarian cancer.
    Lojkin I; Rubinek T; Orsulic S; Schwarzmann O; Karlan BY; Bose S; Wolf I
    Cancer Lett; 2015 Jul; 362(2):149-57. PubMed ID: 25827069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of mucosal iron in the fallopian tube supports the "incessant menstruation hypothesis" for ovarian carcinoma.
    Seidman JD
    Int J Gynecol Pathol; 2013 Sep; 32(5):454-8. PubMed ID: 23896711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
    Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
    van der Leede BM; van den Brink CE; van der Saag PT
    Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
    Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
    Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular distribution of retinoic acid receptor-alpha in benign hyperplastic and malignant human prostates: comparison with androgen, estrogen and progesterone receptor status.
    Gyftopoulos K; Sotiropoulou G; Varakis I; Barbalias GA
    Eur Urol; 2000 Sep; 38(3):323-30. PubMed ID: 10940708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.